Development of quantitative structure-pharmacokinetic relationships

Environmental Health Perspectives
J M Mayer, Han van de Waterbeemd


Quantitative structure-activity relationships (QSAR) relating biological activity to physiochemical descriptors have been successfully used for a number of years. It is also long recognized that pharmacokinetic parameters may play an important and even determinant role in drug action. This prompted several researchers to focus attention to pharmacokinetic parameters as potential descriptors in quantitative drug design. A number of examples of quantitative structure-pharmacokinetic relationships (QSPR) have appeared in the literature. The present contribution reviews some developments in this field. In particular, a number of concepts and problems are critically discussed, rather than compilations of examples already published in recent reviews. Attention will be paid to the main processes of the pharmacokinetic or toxicokinetic phase in drug action, including absorption, distribution and elimination (biotransformation and excretion). It is clear that quantitative approaches are of considerable interest to toxicologists, since these methods may contribute to the development of real predictive toxicology.


Dec 1, 1979·The Journal of Pharmacy and Pharmacology·S Toon, M Rowland
Apr 1, 1977·Journal of Pharmaceutical Sciences·J J Vallner
Sep 1, 1979·Journal of Pharmaceutical Sciences·A GarziaG Tuccini
Sep 1, 1979·Journal of Pharmaceutical Sciences·S Oie, T N Tozer
Aug 1, 1979·Journal of Pharmacokinetics and Biopharmaceutics·W A Colburn
Jan 1, 1978·Chemico-biological Interactions·J S WishnokW M Rand
Jul 1, 1978·Clinical Pharmacology and Therapeutics·M GibaldiP J McNamara
Nov 1, 1978·Chemical & Pharmaceutical Bulletin·J Watanabe, A Kozaki
Jan 1, 1976·Clinical Pharmacokinetics·W S Nimmo
Jan 1, 1976·Drug Metabolism Reviews·W J Jusko, M Gretch
Sep 30, 1975·Annals of the New York Academy of Sciences·J E HalverE M Baker
Apr 1, 1975·Journal of Pharmaceutical Sciences·R N SmithM M Ames
Jun 1, 1975·Journal of Medicinal Chemistry·F E NorringtonR Wootton
Oct 1, 1975·Clinical Pharmacology and Therapeutics·G R Wilkinson, D G Shand
Apr 1, 1973·Journal of Pharmacokinetics and Biopharmaceutics·M RowlandG G Graham
Jan 1, 1972·Journal of Pharmaceutical Sciences·M Rowland
Oct 1, 1969·Journal of Pharmaceutical Sciences·J T DoluisioJ V Swintosky
Jan 1, 1970·Journal of Pharmaceutical Sciences·J T DoluisioL W Dittert
Jul 1, 1967·Journal of Pharmaceutical Sciences·A J AguiarJ C Samyn
Jan 1, 1980·The Journal of Pharmacy and Pharmacology·M K Cassidy, J B Houston
Jul 1, 1981·Clinical Pharmacokinetics·C F George
Jan 1, 1981·Pharmacology & Therapeutics·J K Seydel, K J Schaper
Oct 1, 1983·Journal of Pharmaceutical Sciences·L E Gerlowski, R K Jain
Aug 1, 1983·Journal of Pharmaceutical Sciences·G L AmidonH Lee
Jan 1, 1980·Annals of the New York Academy of Sciences·R CavaliereF S Santori
Jan 1, 1981·Pharmacology & Therapeutics·R E Notari
Dec 1, 1981·British Journal of Clinical Pharmacology·G T Tucker
Jan 1, 1982·Drug Metabolism Reviews·F J Di Carlo
Oct 1, 1982·Journal of Toxicology and Environmental Health·K Enslein, P N Craig
Jan 1, 1981·Journal of Pharmaceutical Sciences·E R CooperR D Bruce
May 1, 1981·Journal of Medicinal Chemistry·F R QuinnJ A Beisler
Oct 1, 1980·Journal of Pharmacokinetics and Biopharmaceutics·M Rowland, G Tucker
Jan 1, 1981·Cancer Chemotherapy and Pharmacology·P Workman, J M Brown
Apr 1, 1981·Journal of Pharmacokinetics and Biopharmaceutics·J M Plá-Delfina, J Moreno
Jun 1, 1981·Journal of Pharmacokinetics and Biopharmaceutics·W A Colburn
Jan 1, 1981·Pharmacology & Therapeutics·D Cutler

❮ Previous
Next ❯


Mar 11, 2000·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M D Garrett, P Workman
Mar 1, 1992·The Journal of Pharmacy and Pharmacology·M Láznícek
Jul 1, 1990·The Journal of Pharmacy and Pharmacology·M LáznícekJ Kvĕtina
Mar 11, 2011·SAR and QSAR in Environmental Research·T Peyret, K Krishnan
Oct 18, 2000·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·M BertrandB Walther
Jul 1, 2010·Expert Opinion on Drug Discovery·Chanin NantasenamatVirapong Prachayasittikul
Oct 16, 2002·Journal of Pharmaceutical Sciences·Donald E Mager, William J Jusko
Mar 27, 2010·Comptes rendus biologies·Wafa Ben-CherifMossadok Ben-Attia
Mar 2, 2016·Advanced Drug Delivery Reviews·Christel A S BergströmChristopher J H Porter
Mar 7, 2009·Chemical Reviews·Stefan Balaz
Jan 31, 2014·Journal of Pharmacological Sciences·Yoshihiro UesawaMasaru Shoji
Nov 30, 2013·Regulatory Toxicology and Pharmacology : RTP·Jos G BessemsJosé-Manuel Zaldívar-Comenges
Mar 3, 2017·Journal of Agricultural and Food Chemistry·Jing-Ting HuangTung-Hu Tsai
Jan 1, 1994·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·P Workman, M A Graham
Jan 10, 2020·Therapeutic Apheresis and Dialysis : Official Peer-reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy·Daisuke SuzukiYoshiaki Matsumoto
Jun 1, 1994·Pharmazie in unserer Zeit·H Kubinyi
Dec 24, 2020·Expert Opinion on Drug Discovery·George Lambrinidis, Anna Tsantili-Kakoulidou

❮ Previous
Next ❯

Related Concepts

Related Feeds


Antiparasitics are medications which are indicated for the treatment of parasitic diseases. Discover the latest research on antiparasitics here.